Indonesia

in page functions
[French]
Indonesia
Total population (2018) 266,356,548
Birth cohort (2018) 4,900,859
Surviving Infants (surviving to 1 year per year, 2018) 4,792,367
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 23/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 27/1000
Gross Nation Income (per capita US$, 2015) 3,440
Co-financing group (2018) Fully self-financing
No. of districts/territories (2017) 514

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Indonesia

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2002 2003 2004 2005 2006 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $193,892,253 $193,917,253 $172,736,633
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $3,900,500 $3,900,500 $4,000,500 103%
Health system strengthening (HSS 1) $24,827,500 $24,827,500 $24,827,500 100%
HepB mono (NVS) $17,511,000 $17,511,000 $17,511,000 100%
HPV Demo (NVS) $184,409 $184,409 $184,009 100%
Immunisation services support (ISS) $12,636,000 $12,636,000 $12,636,000 100%
Injection Safety Devices (NVS) $552,500 $552,500 $348,167 63%
Injection safety support (INS) $9,856,844 $9,856,844 $9,856,844 100%
IPV (NVS) $33,369,500 $33,369,500 $18,943,000 57%
JEV (NVS) $343,500 $343,500 $343,500 100%
Measles-Rubella (NVS) $27,769,500 $27,769,500 $27,769,500 100%
Penta (NVS) $51,176,500 $51,176,500 $44,552,730 87%
Vaccine Introduction Grant (VIG) $11,594,500 $11,594,500 $11,593,883 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Indonesia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 85%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2011) 73.10%
Household survey: DTP3 coverage for female (2011) 70.90%
Household survey: Last DTP3 survey (2011) 72%
% districts achieving > 80% DTP3 coverage (2017) 77%
% districts achieving < 50% DTP3 coverage (2017) 4%
MCV WHO/UNICEF estimates (2017) 75%

Breakdown of support

Non-vaccine support Vaccine support
37% 63%
$63,084,727 $109,651,906

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Indonesia

31 July 2018

INFUSE workshop

Fingerprint records and digital health cards to help solve global identity crisis

Four companies will receive Gavi support to help scale emerging digital identification technologies in developing countries.

26 October 2017

Malawi MR 2017

01 August 2017

President of Indonesia at the measles-rubella vaccine launch

Indonesian Government to immunise 70 million children against measles and rubella

The two-year campaign will aim to reach 95% immunisation coverage in Indonesia.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here